Loss of PTEN activates AKT/mTOR pathways, subsequently activating the expression of SOAT1/2 and contributing to the accumulation of cholesteryl ester and NAFLD-induced HCC (28). Here, PTEN is linked to metabolic dysfunction-associated steatotic liver disease.